Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group To Launch A Longevity & Wellness Initiative Globally; Orgenesis And HSHG Will Establish A JV, With Orgenesis Owning 49% And HSHG Owning 51% Of The Entity; HSHG Has Agreed To Invest Up To $10M Over 3-Years Into Orgenesis And The Joint Venture
Portfolio Pulse from Benzinga Newsdesk
Orgenesis Inc. (NASDAQ:ORGS) has announced a strategic partnership with Harley Street Healthcare Group (HSHG) to launch a global longevity and wellness initiative. The partnership will form a joint venture (JV) with Orgenesis owning 49% and HSHG owning 51%. HSHG will invest up to $10 million over three years into Orgenesis and the JV. The initiative aims to accelerate the development and commercialization of advanced wellness and longevity therapies.
August 14, 2024 | 12:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Orgenesis Inc. has entered into a strategic partnership with Harley Street Healthcare Group to launch a global wellness initiative. The JV will focus on personalized preventative care and regenerative therapies, with HSHG investing up to $10 million over three years.
The partnership and investment from HSHG are likely to positively impact Orgenesis' stock in the short term. The JV will leverage Orgenesis' biotech innovations and HSHG's healthcare network, potentially leading to new revenue streams and market expansion.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100